Cardioprotective effects of remimazolam in elderly hypertensive patients undergoing gastrointestinal tumor surgery: A randomized controlled trial

Table 12 Multivariable logistic regression analysis of factors associated with myocardial injury after non-cardiac surgery

Variable	B	SE	Wald χ2 value	P value	OR	95%CI
						Lower	Upper
Tumor type
Rectal cancer	4.281	1.675	6.534	0.011	72.348	2.714	1928.285
Gastric cancer	3.650	1.526	5.723	0.017	38.475	1.934	765.444
Gastrointestinal stromal tumor	24.031		0.000	1.000		0.000
Anesthesia method
General anesthesia + remimazolam (R group)	-3.188	1.305	5.972	0.015	0.041	0.003	0.532
hs-cTn
T6	-0.105	0.094	1.250	0.263	0.900	0.749	1.082
T7	0.285	0.176	2.624	0.105	1.330	0.942	1.877
T8	-0.041	0.181	0.050	0.823	0.960	0.674	1.368
CK-MB
T6	0.225	0.137	2.699	0.100	1.252	0.958	1.638
T7	-0.001	0.107	0.000	0.989	0.999	0.810	1.230
T8	-0.152	0.140	1.182	0.277	0.859	0.652	1.130
NT-proBNP
T6	-0.004	0.004	1.313	0.252	0.996	0.988	1.003
T7	0.011	0.004	8.340	0.004	1.011	1.004	1.019
T8	-0.009	0.004	5.380	0.020	0.991	0.984	0.999
Operation time	0.015	0.008	3.060	0.080	1.015	0.998	1.032
Constant	-9.040	2.599	12.102	< 0.001	0.000

OR: Odds ratio; CI: Confidence interval; hs-cTn: High-Sensitivity Troponin; CK-MB: Creatine kinase-MB; NT-proBNP: N-terminal pro-brain natriuretic peptide; R group: Experimental group (remimazolam-based intravenous general anesthesia).